ArticleFrontiers in pharmacology2024

IL4I1: a novel molecular biomarker represents an inflamed tumor microenvironment and precisely predicts the molecular subtype and immunotherapy response of bladder cancer.

Xiangrong Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.